NCT06342921View on ClinicalTrials.gov

ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

749

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

October 8, 2023

Study Completion Date

January 22, 2024

Conditions
Safety IssuesEffect of Drug
Interventions
DRUG

15 mg ADC189

Use only once during the whole study.

DRUG

45 mg ADC189

Use only once during the whole study.

DRUG

Placebo

Use only once during the whole study.

Trial Locations (1)

Unknown

Rui Jin Hospital, Shanghai

All Listed Sponsors
lead

Jiaxing AnDiCon Biotech Co.,Ltd

INDUSTRY